Received Registration Approval from NMPA
Edge multi—port endoscopic surgical robot is primarily comprised of three components: the surgeon’s console, the patient-side cart and the 3DHD vision system. Surgeons can comfortably sit at the surgeon’s console and operate and manipulate the robotic arms by viewing the surgical field through a 3DHD vision system during the whole procedure.
A wide array of extensive surgical instruments that can be attached to robotic arms and applied in different procedure types with flexibility comparable to that of human hands, are available for Edge multi—port endoscopic surgical robot.
Edge multi—port endoscopic surgical robot integrates clinical benefits of both open surgery with higher flexibility and accuracy and minimally invasive endoscopic surgery with smaller incision and faster recovery time. It has been proven to be able to perform complex level 4 surgeries in clinical trials, indicating China already has world-class surgical robots in terms of technological capabilities and clinical performance.In December 2022, we received the registration approval from the NMPA for MP1000
Selected complex surgeries performed by Edge multi-port endoscopic surgical robot MP1000:
the only Chinese company included T4 late stage cancer in pivotal clinical trial;
the only Chinese company included radical hysterectomy with lymph node dissection in pivotal clinical trial in gynecology;
the first radical surgery for the treatment of stage IV advanced ovarian cancer completed by a domestic multi-port endoscopic surgical robot;
the first total distal gastrectomy procedure completed by a domestic multi-port endoscopic surgical robot;
the first radical left hemicolectomy procedure completed by a domestic multi-port endoscopic surgical robot.
A wide array of extensive surgical instruments that can be attached to robotic arms and applied in different procedure types with flexibility comparable to that of human hands, are available for Edge multi—port endoscopic surgical robot.
Edge multi—port endoscopic surgical robot integrates clinical benefits of both open surgery with higher flexibility and accuracy and minimally invasive endoscopic surgery with smaller incision and faster recovery time. It has been proven to be able to perform complex level 4 surgeries in clinical trials, indicating China already has world-class surgical robots in terms of technological capabilities and clinical performance.In December 2022, we received the registration approval from the NMPA for MP1000
Selected complex surgeries performed by Edge multi-port endoscopic surgical robot MP1000:
the only Chinese company included T4 late stage cancer in pivotal clinical trial;
the only Chinese company included radical hysterectomy with lymph node dissection in pivotal clinical trial in gynecology;
the first radical surgery for the treatment of stage IV advanced ovarian cancer completed by a domestic multi-port endoscopic surgical robot;
the first total distal gastrectomy procedure completed by a domestic multi-port endoscopic surgical robot;
the first radical left hemicolectomy procedure completed by a domestic multi-port endoscopic surgical robot.